Researchers at the Helmholtz Munich and the Ludwig-Maximilians-University (LMU) Munich have investigated a possible ...

Cirius Therapeutics, Inc., developing innovative therapies for patients suffering from diseases caused by insulin resistance, ...

Significant interaction seen for full psoriasis polygenic risk score with waist-to-hip ratio on psoriasis risk.

Medically reviewed by Amelia MacIntyre, DO Weight loss and fat loss are often confused as the same thing. Weight loss ...

The trial will initially involve healthy obese people receiving single and multiple escalating doses of the therapy.

NEW YORK – Arrowhead Pharmaceuticals on Monday said it has treated the first patients with ARO-ALK7, an RNAi therapeutic that the company is developing for obesity, within a first-in-human Phase I/IIa ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has initiated the human trial of ARO-ALK7, a novel RNA interference (RNAi) ...

However, telangiectasias are also a classic feature of certain autoimmune diseases that affect the skin and other connective tissues (also called connective tissue diseases): There are many different ...

Identifying proteomic signatures of insulin resistance in fasting muscle offers insights for personalized type 2 diabetes ...

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

In recent years, overweight and obesity have become a serious global health problem, posing significant risk factors for ...

Tissue-specific immune memory has become a central focus in immunology, drawing attention to the distinct roles of tissue-resident memory lymphocytes, their ...